Literature DB >> 16953810

The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state.

Thomas M Wickizer1, Antoinette Krupski, Kenneth D Stark, David Mancuso, Kevin Campbell.   

Abstract

Little is currently known about the effect of substance abuse treatment on Medicaid expenses and other health care costs for welfare clients. This study examined the association between substance abuse treatment and reductions in medical care expenditures (primarily Medicaid expenses) for General Assistance (GA) welfare clients in Washington State. The treatment group included 3,235 GA clients who received treatment during 2000 or 2001. The comparison group included 4,863 GA clients who needed substance abuse treatment but did not receive it. Substance abuse treatment was associated with a reduction (p < .01) in medical expenses of approximately 2,500 US dollars annually. This estimated savings equaled the cost of treatment and represented approximately 35 percent of the annual Medicaid expenses incurred by GA clients with substance abuse problems.

Mesh:

Year:  2006        PMID: 16953810      PMCID: PMC2690254          DOI: 10.1111/j.1468-0009.2006.00458.x

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  29 in total

Review 1.  The importance of the normality assumption in large public health data sets.

Authors:  Thomas Lumley; Paula Diehr; Scott Emerson; Lu Chen
Journal:  Annu Rev Public Health       Date:  2001-10-25       Impact factor: 21.981

2.  The effect of alcoholism treatment on medical care use.

Authors:  Robert L Kane; Melanie Wall; Sandra Potthoff; Kurt Stromberg; Yu Dai; Zachary J Meyer
Journal:  Med Care       Date:  2004-04       Impact factor: 2.983

Review 3.  Actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2004-03-10       Impact factor: 56.272

4.  An agenda to combat substance abuse.

Authors:  Steven A Schroeder
Journal:  Health Aff (Millwood)       Date:  2005 Jul-Aug       Impact factor: 6.301

5.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

Review 6.  Alcoholism treatment and potential health care cost saving.

Authors:  H D Holder
Journal:  Med Care       Date:  1987-01       Impact factor: 2.983

7.  Alcoholism treatment and total health care utilization and costs. A four-year longitudinal analysis of federal employees.

Authors:  H D Holder; J O Blose
Journal:  JAMA       Date:  1986-09-19       Impact factor: 56.272

8.  Cost-benefit analysis of drug treatment services: review of the literature*

Authors:  William S. Cartwright
Journal:  J Ment Health Policy Econ       Date:  2000-03-01

9.  Adjusting capitation rates using objective health measures and prior utilization.

Authors:  J P Newhouse; W G Manning; E B Keeler; E M Sloss
Journal:  Health Care Financ Rev       Date:  1989
View more
  8 in total

Review 1.  Using administrative data for longitudinal substance abuse research.

Authors:  Elizabeth Evans; Christine E Grella; Debra A Murphy; Yih-Ing Hser
Journal:  J Behav Health Serv Res       Date:  2008-08-05       Impact factor: 1.505

2.  Cross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome Project.

Authors:  Yih-Ing Hser; Elizabeth Evans
Journal:  Eval Program Plann       Date:  2008-02-19

3.  Effect of eliminating behavioral health benefits for selected medicaid enrollees.

Authors:  K John McConnell; Neal T Wallace; Charles A Gallia; Jeanene A Smith
Journal:  Health Serv Res       Date:  2008-04-01       Impact factor: 3.402

4.  Association Between State Medicaid Eligibility Thresholds and Deaths Due to Substance Use Disorders.

Authors:  Julia Thornton Snider; Margaret E Duncan; Mugdha R Gore; Seth Seabury; Alison R Silverstein; Mahlet G Tebeka; Dana P Goldman
Journal:  JAMA Netw Open       Date:  2019-04-05

5.  Which elements of improvement collaboratives are most effective? A cluster-randomized trial.

Authors:  David H Gustafson; Andrew R Quanbeck; James M Robinson; James H Ford; Alice Pulvermacher; Michael T French; K John McConnell; Paul B Batalden; Kim A Hoffman; Dennis McCarty
Journal:  Addiction       Date:  2013-03-01       Impact factor: 6.526

6.  Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system.

Authors:  Derek D Satre; Vanessa A Palzes; Kelly C Young-Wolff; Sujaya Parthasarathy; Constance Weisner; Joseph Guydish; Cynthia I Campbell
Journal:  J Subst Abuse Treat       Date:  2020-08-04

7.  Testing the effects of brief intervention in primary care for problem drug use in a randomized controlled trial: rationale, design, and methods.

Authors:  Antoinette Krupski; Jutta M Joesch; Chris Dunn; Dennis Donovan; Kristin Bumgardner; Sarah Peregrine Lord; Richard Ries; Peter Roy-Byrne
Journal:  Addict Sci Clin Pract       Date:  2012-12-14

8.  Association between supportive interventions and healthcare utilization and outcomes in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a systematic review and meta-analysis.

Authors:  Jean Deschamps; James Gilbertson; Sebastian Straube; Kathryn Dong; Frank P MacMaster; Christina Korownyk; Lori Montgomery; Ryan Mahaffey; James Downar; Hance Clarke; John Muscedere; Katherine Rittenbach; Robin Featherstone; Meghan Sebastianski; Ben Vandermeer; Deborah Lynam; Ryan Magnussen; Sean M Bagshaw; Oleksa G Rewa
Journal:  BMC Emerg Med       Date:  2021-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.